Disease/Infection News

RSS

Study reveals a dramatic increase in TTB cases

Babesiosis is a potentially dangerous parasitic disease transmitted by ticks and is common in the Northeast and the upper Midwest. Babesia lives inside of red blood cells, meaning it can also be transmitted through a blood transfusion from an infected but otherwise asymptomatic blood donor.

21 Oct 2009

Aethlon Hemopurifier effective in capturing H1N1 Swine Flu Virus

Aethlon Medical, Inc. announced today that research studies have documented the Aethlon Hemopurifier® is effective in capturing the current pandemic strain of the H1N1 Swine Flu Virus. The Hemopurifier® is the first-in-class medical device able to selectively remove infectious viruses and immunosuppressive proteins from the bloodstream.

21 Oct 2009

Contribution of glycosaminoglycans to skeletal abnormalities in patients with lysosomal storage diseases demonstrated

A group led by Dr. Dieter Br-mme at the University of British Columbia has demonstrated that glycosaminoglycans (GAGs) contribute to skeletal abnormalities in patients with lysosomal storage diseases. Their report can be found in the November 2009 issue of The American Journal of Pathology.

21 Oct 2009

Dutch researcher sheds new light on coronaviruses

Using novel techniques, Dutch researcher Matthijs Raaben has cast new light on the replication of coronaviruses, a family of viruses including the cause of SARS. He has shown, using luminescent viruses, how coronaviruses use host cells and how we can use the intracellular processes to attack the virus.

21 Oct 2009

New public health tool to identify all Tier 1 candidates for H1N1 vaccination

Practice Fusion Inc. (www.practicefusion.com), the free, web-based electronic health record (EHR) for physicians, today implemented a first-of-its-kind tool that allows its physician-users to immediately and accurately identify all Tier 1 candidates for H1N1 vaccination from their patient populations using criteria published by the Centers for Disease Control and Prevention (CDC).

21 Oct 2009

Duke Abdominal Assessment Scale can help predict NEC disease in newborns

Radiologists at Duke University Medical Center have developed a scale called the Duke Abdominal Assessment Scale (DAAS) to assist clinicians in determining the severity of disease and the need for surgery in infants with necrotizing enterocolitis (NEC), according to a study in the November issue of the American Journal of Roentgenology.

21 Oct 2009

Swine flu treatments, safety issues prompt health workers to speak out

In anticipation of new swine flu cases, medical workers are looking for new ways help their patients - and protect themselves.

21 Oct 2009

CHA urges California Nurses Association to promote vaccinations to all health care workers

The California Hospital Association (CHA) is engaged with hospitals and state and local public health officials in a voluntary statewide effort to ensure that all hospital workers -- including registered nurses -- are vaccinated against the H1N1 flu virus.

21 Oct 2009

Bill & Melinda Gates Foundation's initiative to transform health in developing countries

The Bill & Melinda Gates Foundation today announced 76 grants of US$100,000 each to pursue bold ideas for transforming health in developing countries. The grants support researchers across 16 countries, including nine in Europe and Africa with ideas as diverse as using the power of sunlight to kill malaria-causing mosquito larvae and developing a device that repels mosquitoes without insecticides.

21 Oct 2009

Grady Memorial Hospital uses LiveProcess event log for emergency healthcare management

Facilities like Atlanta, Georgia-based Grady Memorial Hospital are taking extra precautions, including leveraging technology for emergency healthcare management, in anticipation of a H1N1 surge this fall.

21 Oct 2009

Nationwide H1N1 Event Log to help ongoing challenges of flu pandemic

LiveProcess launched a nationwide H1N1 Event Log on October 1 designed to help regional healthcare organizations more effectively deal with the expected patient surge, consolidate the massive flow of disease-related communications and coordinate regional events with their constituent hospitals and other healthcare facilities.

21 Oct 2009

Rice University scientists win NIH stimulus funds to study influenza A

Rice University scientists have won a $1.5 million grant from the National Institutes of Health to scrutinize the influenza A virus for clues that could lead to more effective antiviral drugs. Strains of influenza A include this year's pandemic H1N1 variety, some seasonal varieties and the much-feared H5N1 bird flu.

21 Oct 2009

Also in Global Health News: Cholera in Zimbabwe; personal computers; medical 'outliers'; rain in Kenya; generic drugs

A cholera outbreak in Zimbabwe has infected more than 100, resulting in five deaths, state media said Tuesday, Reuters reports, "raising fears of a repeat of last year's epidemic that claimed more than 4,000 lives.

21 Oct 2009

World Medical Association adopts climate change, task shifting resolutions

At its general assembly in New Delhi, India, the World Medical Association (WMA), "a conglomerate of medical associations around the world," approved a plan that aims "to minimise the risk of increased malnutrition deaths, diseases and injuries due to climate change," IANS/Thaindian News reports (10/17).

20 Oct 2009

As HIV vaccine conference opens, experts appeal for sustained commitment to global fight against disease

Experts, gathered for the start of a four-day conference on HIV vaccines in Paris, called upon donors to maintain their funding support for the fight against HIV/AIDS despite the global economy, Agence France-Presse reports.

20 Oct 2009

Boehringer Ingelheim continues providing non assert declarations to manufacture HIV/AIDS medicines

Boehringer Ingelheim continues to be willing to provide WHO qualified generic pharmaceutical companies non assert declarations to manufacturer and export products containing the HIV/AIDS medication nevirapine to Rwanda and other defined developing countries.

20 Oct 2009

GlaxoSmithKline to allow Apotex continue manufacturing their drug in Rwanda

GlaxoSmithKline Inc. (GSK) As part of its broad commitment to improving access to medicines and its ongoing support for Canada's Access to Medicines Regime (CAMR), GlaxoSmithKline confirms it will not object - through CAMR - to allow Canadian company (Apotex) to continue manufacturing their drug for the treatment of HIV/AIDS in Rwanda.

20 Oct 2009

Disease/Infection News

Study reveals a dramatic increase in TTB cases

Aethlon Hemopurifier effective in capturing H1N1 Swine Flu Virus

Contribution of glycosaminoglycans to skeletal abnormalities in patients with lysosomal storage diseases demonstrated

Dutch researcher sheds new light on coronaviruses

New public health tool to identify all Tier 1 candidates for H1N1 vaccination

Duke Abdominal Assessment Scale can help predict NEC disease in newborns

Swine flu treatments, safety issues prompt health workers to speak out

CHA urges California Nurses Association to promote vaccinations to all health care workers

Bill & Melinda Gates Foundation's initiative to transform health in developing countries

Grady Memorial Hospital uses LiveProcess event log for emergency healthcare management

Nationwide H1N1 Event Log to help ongoing challenges of flu pandemic

Rice University scientists win NIH stimulus funds to study influenza A

Also in Global Health News: Cholera in Zimbabwe; personal computers; medical 'outliers'; rain in Kenya; generic drugs

World Medical Association adopts climate change, task shifting resolutions

As HIV vaccine conference opens, experts appeal for sustained commitment to global fight against disease

Boehringer Ingelheim continues providing non assert declarations to manufacture HIV/AIDS medicines

GlaxoSmithKline to allow Apotex continue manufacturing their drug in Rwanda

Coworkers should remain home if infected with H1N1 flu virus, says majority of Americans

PCV vaccines can save the lives of millions of children

Elan and Biogen Idec to present TYSABRI study data at ACG meeting

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News